2. Signaling Pathways
  3. GPCR/G Protein
  4. CRFR
  5. CRFR1 Isoform
  6. CRFR1 Inhibitor

CRFR1 Inhibitor

CRFR1 Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-113603
    Tildacerfont
    		Inhibitor 98.25%
    Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia.